Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,604,000 | 7,214,000 | 5,433,000 | 4,234,000 | 2,480,000 |
| Marketable Securities | 1,293,000 | 2,109,000 | 2,258,000 | 1,808,000 | 1,898,000 |
| Receivables | 2,374,000 | 2,451,000 | 2,327,000 | 2,066,000 | 2,120,000 |
| Inventories | 451,000 | 464,000 | 442,000 | 458,000 | 510,000 |
| Other current assets | 732,000 | 445,000 | 521,000 | 501,000 | 819,000 |
| TOTAL | $14,454,000 | $12,683,000 | $10,981,000 | $9,067,000 | $7,827,000 |
| Non-Current Assets | |||||
| PPE Net | 1,415,000 | 1,400,000 | 1,383,000 | 1,367,000 | 1,313,000 |
| Intangibles | 24,390,000 | 23,994,000 | 24,104,000 | 24,216,000 | 24,346,000 |
| Other Non-Current Assets | 1,104,000 | 1,106,000 | 1,171,000 | 830,000 | 729,000 |
| TOTAL | $26,909,000 | $26,500,000 | $26,658,000 | $26,413,000 | $26,388,000 |
| Total Assets | $41,363,000 | $39,183,000 | $37,639,000 | $35,480,000 | $34,215,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,498,000 | N/A | 500,000 | 501,000 | 502,000 |
| Accounts payable and accrued liabilities | 421,000 | 327,000 | 340,000 | 418,000 | 292,000 |
| Accrued Expenses | 2,964,000 | 3,035,000 | 2,975,000 | 2,987,000 | 2,705,000 |
| TOTAL | $5,009,000 | $3,685,000 | $3,955,000 | $4,057,000 | $3,683,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,289,000 | 19,790,000 | 19,781,000 | 19,769,000 | 19,742,000 |
| Deferred Revenues | 44,000 | 43,000 | 68,000 | 73,000 | 79,000 |
| Other Non-Current Liabilities | 3,108,000 | 2,941,000 | 2,948,000 | 2,667,000 | 3,045,000 |
| TOTAL | $24,267,000 | $25,447,000 | $25,519,000 | $25,262,000 | $25,672,000 |
| Total Liabilities | $29,276,000 | $29,132,000 | $29,474,000 | $29,319,000 | $29,355,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 711,715 | 708,741 | 705,260 | 702,164 | 699,252 |
| Common Shares | 10,000 | 10,000 | 10,000 | 10,000 | 10,000 |
| Retained earnings | 22,366,000 | 20,675,000 | 19,104,000 | 17,559,000 | 16,486,000 |
| Other shareholders' equity | -27,000 | -56,000 | -32,000 | -50,000 | -77,000 |
| TOTAL | $12,087,000 | $10,051,000 | $8,165,000 | $6,161,000 | $4,860,000 |
| Total Liabilities And Equity | $41,363,000 | $39,183,000 | $37,639,000 | $35,480,000 | $34,215,000 |